Artwork

コンテンツは Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

Ep71: Learning from AI: Lessons for Digital Therapeutic Pioneers

34:47
 
シェア
 

Manage episode 372830575 series 2857558
コンテンツは Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 つのエピソード

Artwork
iconシェア
 
Manage episode 372830575 series 2857558
コンテンツは Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 つのエピソード

すべてのエピソード

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド